ArticleMethods in molecular biology (Clifton, N.J.)2026
Quantification of C2C12 Myoblast Differentiation by Flow Cytometry.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
C2C12 myoblasts are widely used as an in vitro model to study skeletal muscle cell differentiation. Here, we update our previously published flow cytometry-based protocol to quantify C2C12 cell differentiation by measuring myosin heavy-chain (MyHC) marker expression. We explain the procedures for daily maintenance, transfection, induction of C2C12 cell differentiation, immunolabeling, and flow cytometry acquisition settings. We emphasize the importance of optimized cell seeding density to enhance transfection or differentiation efficiency and clarify the critical role of the correct cell population gate to accurately quantify MyHC-positive cells. Both the effect of drug treatments and genetic manipulations can be analyzed in this way. As an example, we quantify the disruption and rescue of differentiation only of the transformed, GFP-positive cell population after expression of mEGFP-tagged oncogenic K-Ras.
Indexed as
Identifiers
42867820What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.